Physician profile
Robert J Cerfolio
NPI 1245272483
$96,602.97
in general payments reported to CMS, 2019-2025
11 companies · $29K in 2025
The $29K reported for 2025 was more than what 95% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63K · 2021: $123 · 2022: $1,135 · 2023: $329 · 2024: $2,476 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $1,832 · Food and Beverage: $1,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,250.00 |
| Travel and Lodging | $1,831.59 |
| Food and Beverage | $1,364.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $72,683.22 | 2019-2025 | |
| Ethicon INC. | $16,493.82 | 2019-2025 | Surgicel Nu-Knit |
| Medela Ag | $3,600.00 | 2025 | Thopaz |
| Medela LLC | $2,250.00 | 2024 | Art. 101030215 Thopaz+ Chest Drainage |
| Conmed Corporation | $715.93 | 2025 | Airseal |
| Baxter Healthcare | $295.97 | 2021-2025 | Floseal, Perclot, Tisseel |
| Ambu INC. | $261.76 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $133.57 | 2025 | Tagrisso |
| Edwards Lifesciences Corporation | $82.66 | 2022 | |
| Atricure, INC. | $64.92 | 2024-2025 | Atriclip Laa Exclusion System |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $21.12 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cerfolio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.